Half a Million Packages of Prescription Drugs Recalled after Child Opens Child-Resistant Package

Comments (0)

The drug company Novartis issued a voluntary recall of 470,000 packages of drugs after a child opened and swallowed a pill from a child-resistant package. There are 12 different medications from Novartis that will be recalled. All are packaged as blister packs. Under regulations issued by the Consumer Product Safety Commission, prescription drugs are required to be child-resistant.

The child opened and took haloperidol, which is an antipsychotic medication used in the treatment of schizophrenia and other neurological disorders. The company said that it reviewed all blister packs and discovered that some blister packs for other medications were not child-resistant.

While the recall is ongoing, in order to avoid a shortage of medications, the company announced it would offer child-resistant, re-sealable pouches to patients for stores of the blister packs in their homes. When the patient refilled the prescription, the new prescription will be dispensed in child-resistant packaging. According to the company, there are no safety issues regarding the medication itself, only the packaging.

Drug companies are under an obligation to consumers to not only make drugs that are safe for the public, but to also correctly package those drugs. If a drug company makes a dangerous drug, or if it fails to safely package the drugs, the drug company can be held legally liable for any damages that are incurred as a result.

If you have been harmed by a prescription drug, you should speak with an attorney. Call the attorneys at Kennedy Hodges at 855-947-0707. Our legal team can help and will provide you with a free consultation. You can also learn more about the firm on Twitter.

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.